Maxcyte (MXCT) Depreciation & Amortization (IS) (2021 - 2026)
Maxcyte (MXCT) reported Depreciation & Amortization (IS) of $1.0 million for Q1 2026, down 4.24% year-over-year from $1.1 million in Q1 2025, and down 2.4% on a QoQ basis from $1.0 million in Q4 2025.
Maxcyte (MXCT) has 6 years of Depreciation & Amortization (IS) data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Depreciation & Amortization (IS) fell 4.24% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (up 1.09% YoY) and the FY2025 annual result came in at $4.2 million, up 2.0% from the prior year.
- Depreciation & Amortization (IS) retreated to $1.0 million in Q1 2026 per MXCT's latest filing, from $1.0 million in the prior quarter.
- Across five years, Depreciation & Amortization (IS) topped out at $1.1 million in Q2 2025 and bottomed at $447300.0 in Q1 2022.
- The 5-year median for Depreciation & Amortization (IS) is $1.0 million (2024), against an average of $935170.6.
- The widest annual swing landed in 2022, when Depreciation & Amortization (IS) surged 128.96%; it then dropped 4.24% in 2026.
- Tracing MXCT's Depreciation & Amortization (IS) over 5 years: stood at $873700.0 in 2022, then grew by 21.67% to $1.1 million in 2023, then decreased by 4.05% to $1.0 million in 2024, then gained by 2.06% to $1.0 million in 2025, then slipped by 2.4% to $1.0 million in 2026.
- Per Business Quant, the three latest MXCT Depreciation & Amortization (IS) figures stand at $1.0 million (Q1 2026), $1.0 million (Q4 2025), and $1.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 310.25 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.04 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 977,000.00 |
| Mar 31, 2023 | 912,000.00 |
| Dec 31, 2022 | 873,700.00 |
| Sep 30, 2022 | 709,800.00 |
| Jun 30, 2022 | 497,100.00 |
| Mar 31, 2022 | 447,300.00 |
| Dec 31, 2021 | 381,600.00 |
| Sep 30, 2021 | 333,100.00 |
| Jun 30, 2021 | 322,900.00 |
| Mar 31, 2021 | 311,600.00 |